FHIR © HL7.org  |  Server Home  |  XIG Home  |  XIG Stats  |  Server Source  |  FHIR  

FHIR IG Statistics: FHIR Resources

ValueSets, Realm US

13,139 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 11,158

 

Start Prev Rows 10000 - 10200 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
signal.core.r4R4coverage-financial-exceptionExample Coverage Financial Exception Codesdraft1fm2019-10hl7tho
hl7.fhir.us.carin-bbR4C4BBSurfaceCodesUS Surface Codes Set Value Settrial-usefm2025-02hl7tho
hl7.fhir.us.pacio-pfeR4pfe-sensory-functions-pain-clinical-test-vsPersonal Functioning and Engagement Sensory Functions and Pain Clinical Test Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-goals-self-care-vsPersonal Functioning and Engagement Goals Self-Care Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-goals-mobility-vsPersonal Functioning and Engagement Goals Mobility Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-learning-and-applying-knowledge-vsPersonal Functioning and Engagement Learning and Applying Knowledge Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-self-care-vsPersonal Functioning and Engagement Self-Care Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-body-structures-vsPersonal Functioning and Engagement Body Structures Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-communication-vsPersonal Functioning and Engagement Communication Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-functions-of-digestive-vsPersonal Functioning and Engagement Functions Of Digestive, Metabolic, and Endocrine Systems Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-domestic-life-vsPersonal Functioning and Engagement Domestic Life Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-genitourinary-vsPersonal Functioning and Engagement Genitourinary and Reproductive Functions Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-mental-functions-vsPersonal Functioning and Engagement Mental Functions Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-mobility-vsPersonal Functioning and Engagement Mobility Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-neuromusculoskeletal-vsPersonal Functioning and Engagement Neuromusculoskeletal and Movement Related Functions Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-sensory-functions-pain-vsPersonal Functioning and Engagement Sensory Functions and Pain Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-skin-functions-vsPersonal Functioning and Engagement Functions of Skin and Related Structures Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-structures-voice-and-speech-vsPersonal Functioning and Engagement Structures Involved in Voice and Speech Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-voice-and-speech-vsPersonal Functioning and Engagement Voice and Speech Functions Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-products-and-technology-vsPersonal Functioning and Engagement Products and Technology Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-goals-panel-vsPersonal Functioning and Engagement Goals Panel Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.pacio-pfeR4pfe-panel-vsPersonal Functioning and Engagement Panel Value Settrial-use3pc2025-07hl7loinc
hl7.fhir.us.davinci-cdexR4cdex-loinc-attachment-codesCDex LOINC Attachment Codes Value Settrial-use2claims2022-06hl7loinc
hl7.fhir.us.davinci-pasR4pas-loinc-attachment-codesPAS LOINC Attachment Codes Value Settrial-use3fm2022-06hl7loinc
hl7.fhir.us.carin-bbR4C4BBProfessionalAndNonClinicianClaimSubTypeC4BB Professional And Non Clinician Claim SubType Value Settrial-usefm2025-02hl7tho
hl7.fhir.us.carin-bbR4C4BBProfessionalAndNonClinicianClaimTypeC4BB Professional And Non Clinician Claim Type Value Settrial-usefm2025-02hl7tho
signal.core.r4R4fm-statusFinancial Resource Status Codesdraft2fm2019-10hl7fhir
fhir.deep6.aiR4deep-6-ai-documentreference-categoryDeep 6 AI DocumentReference Category Value Setactive2023-12hl7internal
fhir.deep6.aiR4deep-6-ai-location-typeDeep 6 AI Location Type Value Setactive2023-08hl7internal tho
fhir.deep6.aiR4deep-6-ai-location-physical-typeDeep 6 AI Location Physical Type Value Setactive2023-11hl7internal fhir
hl7.fhir.us.qicoreR4qicore-medication-dose-typeQICore SNOMED CT Dosage Codestrial-use4cqi2018-08hl7sct
hl7.fhir.us.insurance-cardR4C4DICContactTypeVSC4DIC Contact Typeactiveclaims2024-04hl7fhir tho
hl7.fhir.us.insurance-cardR4C4DICCopayTypeVSC4DIC Copay Typeactiveclaims2024-04hl7fhir
hl7.fhir.us.insurance-cardR4C4DICCoverageClassVSC4DIC Coverage Classactiveclaims2024-04hl7fhir tho
signal.core.r4R4subscriber-relationshipSubscriberPolicyholder Relationship Codestrial-use2fm2019-10hl7tho
hl7.fhir.us.pacio-pfeR4pfe-category-vsPersonal Functioning and Engagement Category Value Settrial-use3pc2025-07hl7fhir
hl7.fhir.us.carin-rtpbcR4rtpbc-prescribable-product-codeRTPBC Prescribable Product Code Value Settrial-use4phx2020-05hl7rx ndc
signal.core.r4R4languagesCommon Languagesdraft5fm2016-08hl7ietf
us.cdc.phinvadsR42.16.840.1.114222.4.11.3204Non-Laboratory Intervention and Procedureactive2009-01sct
signal.core.r4R4coverage-copay-typeCoverage Copay Type Codestrial-use2fm2019-10hl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1111.146Buprenorphineactive2022-03hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1111.166Codeine Schedule II and IIIactive2023-03hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1111.167Alfentanilactive2021-02hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1111.168Remifentanilactive2021-02hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1111.169Sufentanilactive2021-02hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1125.1Schedule IV Benzodiazepinesactive2025-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.11Oxycodoneactive2023-03hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.12Oxymorphoneactive2022-03hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.70Morphineactive2024-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.71Methadone Medicationsactive2021-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.72Meperidineactive2024-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.73Levorphanolactive2021-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.74Hydromorphoneactive2021-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.75Hydrocodoneactive2025-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1002.76Fentanylactive2024-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.12Butorphanolactive2021-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.15Opium Combinationsactive2024-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.16Pentazocineactive2024-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.17Tapentadolactive2021-02hl7rx
us.nlm.vsacR42.16.840.1.113883.3.3157.1004.18Tramadolactive2024-02hl7rx
hl7.fhir.us.mihrR4hypertensive-disorders-pregnancy-ICDValueSet – Hypertensive Disorders of Pregnancy ICDdraft2023-03hl7icd
hl7.fhir.us.mihrR4hypertensive-disorders-pregnancy-SNOMEDValueSet – Hypertensive Disorders of Pregnancy SNOMED CTdraft2023-03hl7sct
hl7.fhir.us.eltssR4eltss-observation-codeObservation Code Value Setinformativehsswg2019-09hl7fhir loinc
us.nlm.vsacR42.16.840.1.113883.11.20.9.69.6Planned or Completed moodCodeactive2024-06hl7tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7664Data Elements (NND Babesiosis)active2018-01sct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7811Data Elements (CRS)active2018-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7525Data Elements (NND CS)active2018-01oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7663Data Elements (NND Malaria)active2018-01sct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7816Data Elements (Rubella)active2018-01sct oid loinc
us.cdc.phinvadsR42.16.840.1.114222.4.11.7665Data Elements (NND Varicella)active2018-01sct oid loinc
hl7.fhir.us.pacio-tocR4toc-loinc-answered-by-LL5571-6-vsTransitions of Care LOINC Terms Answered by LL5571-6 Answer List Value Settrial-use2pc2025-06hl7loinc
hl7.fhir.us.pacio-tocR4toc-del-loinc-vsTransitions of Care DEL LOINC Terms Value Settrial-use2pc2025-06hl7loinc
hl7.fhir.us.pacio-tocR4toc-del-loinc-answered-by-LL5571-6-vsTransitions of Care LOINC Terms Included in the DEL Answered by LL5571-6 Answer List Value Settrial-use2pc2025-06hl7fhir
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.38Current Smoking Status (NAACCR)active2015-01sct
us.nlm.vsacR42.16.840.1.113762.1.4.1099.28Problem Type (LOINC)active2023-07hl7loinc
us.nlm.vsacR42.16.840.1.113883.11.20.9.39Result Statusactive2024-06hl7tho
us.nlm.vsacR42.16.840.1.113762.1.4.1078.476Allergy To Vaccine Componentactive2023-07hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1115.2InstructionActStatusactive2017-11hl7tho
us.nlm.vsacR42.16.840.1.113883.11.20.9.69.7Obligation or Prohibition Instruction Typeactive2017-11hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1096.58Findings Related to Medication Management, Chronic Disease Presentactive2023-12hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1096.59Findings Related to Medication Management, Taking Medication for Chronic Diseaseactive2017-08hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1219.150Fall or Fall Risk from Wheelchair or Scooter ICD10CMactive2022-03hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1219.147Mobility Impairment or Fall From Chair ICD10CMactive2022-03hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1219.144Bed Confinement Impairmentactive2022-03hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.302Test Cervical Excision Proceduresactive2023-10hl7sct
us.cdc.phinvadsR42.16.840.1.114222.4.11.7449Qualitative Lab Result (RCMT)active2016-01sct
hl7.fhir.us.coreR4us-core-screening-assessment-observation-maximum-categoryUS Core Screening Assessment Observation Maximum Categorytrial-use3cgp2024-11hl7fhir tho
hl7.fhir.us.coreR4us-core-simple-observation-categoryUS Core Simple Observation Categorytrial-use3cgp2024-11hl7fhir tho
us.nlm.vsacR42.16.840.1.113883.11.20.9.87Postpartum Statusactive2024-06hl7sct
us.nlm.vsacR42.16.840.1.113883.3.3157.190123Diagnostic Mammography Studyactive2018-04hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.3157.1902Ultrasound of the Breastactive2019-01hl7cpt
us.nlm.vsacR42.16.840.1.113883.3.3157.190412Screening Mammography and DBT Studiesactive2018-04hl7vsac
us.nlm.vsacR42.16.840.1.113883.3.3157.4066Diagnostic DBT Studyactive2022-05hl7vsac
us.nlm.vsacR42.16.840.1.13883.3.3157.4067MRI of the Breastactive2024-06hl7cms
us.nlm.vsacR42.16.840.1.13883.3.3157.4068MRI of the Breastactive2022-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1267.25Detailed race including absence reasons.active2025-04hl7vsac
us.cdc.phinvadsR42.16.840.1.114222.4.11.6066Ethnic Group (HL7)active2012-01tho
us.nlm.vsacR42.16.840.1.113762.1.4.1115.6Personal Health Goals LOINCactive2024-07hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1115.13Healthcare Agent Powers or Limitations Indicatoractive2024-11hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1221.208Sexual Orientationactive2024-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.264CDS Pregnancyactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1032.265CDS Pregnancy Intensionalactive2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.11Cirrhosis ICD9CMactive2024-06hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1032.13Cirrhosis SNOMEDCTactive2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.14Cirrhosisactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1221.179Abortion Medicationsactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1221.184Letrozole (Aromatase inhibitor)active2024-04hl7rx
us.nlm.vsacR42.16.840.1.113762.1.4.1260.12Negativeactive2023-08hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1095.11Nutrition Focused Physical Findings SNOMED CTactive2025-01hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1096.207PharmacyEnvironmentsOfCareactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.205PharmacyTypeOfProfessionactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.181PharmacyEncounterReasonactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.197PharmacyAllergiesactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.198PharmacyInterventionsactive2024-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.200PharmacyReasonsForInterventionsactive2024-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.201PharmacyInterventionStatusactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.202PharmacyCareCoordinationactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.203PharmacyReferralsToactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.204PharmacyGoalStatusOutcomeactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.208PharmacyEncounterTypeactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.209PharmacytEncounterClassactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.211PharmacyAllergyIntoleranceTypeactive2018-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.212PharmacyAllergyIntoleranceManifestationactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.213PharmacyReasonForMedicationChangeactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.214PharmacyEducationactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.215PharmacyEducationStatusactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1096.216PharmacyReferralsFromactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1115.7Health Goals Groupingactive2022-03hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1221.177Mifepristoneactive2024-04hl7rx
hl7.fhir.us.coreR4us-core-screening-assessment-observation-categoryUS Core Screening Assessment Observation Categorytrial-use3cgp2024-11hl7fhir tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7880Education (CO)active2019-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7884Exposure Site Category (CO)active2022-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7881Generator Location (CO)active2019-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7876Intent of Exposure (CO)active2019-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7882Generator Distance (CO)active2019-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7878Exposure Source (CO)active2019-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7888Signs and Symptoms (CO)active2019-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7877Extreme Weather Type (CO)active2022-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7891Data Reporting Source (CO)active2019-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7887Underlying Conditions (CO)active2019-01sct tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7883Person/Organization Taking CO Reading (CO)active2019-01tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7886Treatment Location (CO)active2019-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7879Treatment Type (CO)active2019-01sct tho
us.nlm.vsacR42.16.840.1.113762.1.4.1248.107Mechanical Ventilationactive2022-05hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1248.109aPTT Testsactive2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1248.106Mechanical Ventilationactive2024-01hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1032.96Dependence on dialysisactive2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1166.117Syphilis Testsactive2023-07hl7loinc
us.nlm.vsacR42.16.840.1.113883.1.11.20.2.9Nutrition Recommendationsactive2018-05hl7sct
us.nlm.vsacR42.16.840.1.113883.1.11.15913EntityNameUseactive2024-06hl7tho
us.cdc.phinvadsR42.16.840.1.114222.4.11.7874Poison Control Center Record (CO)active2019-01sct tho oid
us.cdc.phinvadsR42.16.840.1.114222.4.11.7875Workers Compensation Record (CO)active2021-12tho oid
us.nlm.vsacR42.16.840.1.113762.1.4.1116.365Hospice Care Referral or Admissionactive2025-05hl7sct
us.nlm.vsacR42.16.840.1.113883.3.3157.2Abdomen CT with contrastactive2020-07hl7cpt
us.nlm.vsacR42.16.840.1.113883.3.3157.21Abdomen CT Without then With Contrastactive2020-07hl7cpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1Abdomen CT without contrastactive2020-07hl7cpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1017Adrenal Massactive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1020Hematuriaactive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1021Infections of Kidneyactive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1022Jaundiceactive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1023Liver Lesion (Mass or Neoplasm)active2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1024Malignant Neoplasm of Bladderactive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1025Malignant Neoplasm of Pancreasactive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1026Non Traumatic Aortic Diseaseactive2023-11hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1028Unspecified Disorder of Kidney and Ureteractive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1805MRI Lumbar Spine Proceduresactive2020-07hl7cpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1802Physical Therapyactive2020-07hl7cpt
us.nlm.vsacR42.16.840.1.113883.3.3157.1812Biomechanical Lesions (not Elsewhere Classified)active2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1809Other Deforming Dorsopathiesactive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1813Dislocation or Sprain of those Joints and Ligaments Located in the Lumbar Spine or Pelvisactive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1811Other Dorsopathiesactive2021-04hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1810Spondylopathiesactive2020-07hl7icd
us.nlm.vsacR42.16.840.1.113883.3.3157.1803Chiropractic Evaluationactive2020-07hl7cpt
us.nlm.vsacR42.16.840.1.13883.3.3157.4069Intraspinal Abscessactive2022-09hl7icd
us.cdc.phinvadsR42.16.840.1.113883.11.20.9.25Planned moodCode - Observation (HL7)active2014-12tho
us.nlm.vsacR42.16.840.1.113762.1.4.1221.203Intersex Surgery, Allactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1221.192Infertility, Allactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1099.59Medication Adherence SCTactive2024-03hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1240.8Medication Adherenceactive2023-10hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1078.599PIM_Vitamin B12 Level_LOINC_CPTactive2023-09hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1222.1015Substance Useactive2023-07hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1222.1016Tobacco Useactive2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1222.1064Marital or Spousal Statusactive2024-06hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1222.1548Cerebrovascular Disease Diagnosis SCTactive2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1222.1559Metabolic Syndrome Diagnosis SCTactive2024-06hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1222.1585Alcohol Use Related Questionnaire Panel Codesactive2024-03hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1222.1586Functional Status Related Questionnaire Panel Codesactive2024-05hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1222.642Intracranial Stenosisactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1222.742Hypertriglyceridemiaactive2024-07hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1222.757Restless Leg Syndromeactive2024-06hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1222.807Triiodothyronine in serum or plasmaactive2024-07hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1222.910Abdominal MRIactive2024-05hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1222.925Foot MRIactive2024-07hl7loinc
us.nlm.vsacR42.16.840.1.113762.1.4.1221.166Abortion, Surgical Managementactive2024-04hl7cpt
us.nlm.vsacR42.16.840.1.113762.1.4.1221.167Abortion, Surgical Managementactive2024-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1221.168Abortion, Surgical Managementactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1221.180Contraception, Surveillanceactive2024-04hl7sct
us.nlm.vsacR42.16.840.1.113762.1.4.1221.181Contraception, Surveillanceactive2024-04hl7icd
us.nlm.vsacR42.16.840.1.113762.1.4.1221.182Contraception, Surveillanceactive2024-04hl7vsac
us.nlm.vsacR42.16.840.1.113762.1.4.1221.186Infertility, Femaleactive2024-04hl7icd